Glaucoma 360

Paul P. Lee MD, JD: Glaucoma 360 can be very useful for the practicing ophthalmologist in a variety of ways. 360 is an event that spans a couple of days. So there’s a Forum where innovation is discussed. We have people from the FDA for the companies, but there’s also a wonderful symposium of education focused on clinical care for glaucoma on Saturday. And so it’s a way for individuals to see what’s going on, what the new products are, to be able to respond to patient questions, as well as to get practical insights on how to cure for glaucoma patients from some of the leading glaucoma specialists around the country.

Thomas W. Samuelson, MD: It’s more than a meeting. It’s like a glaucoma trifecta. It starts with a great celebration on Thursday night, which is, I believe unique to glaucoma meetings. The next day is basically a think-tank, an all day long session that you learn about new innovation and technology. And then finally the final day is kind of a collaborative sharing of ideas among clinicians. So it’s really a trifecta of glaucoma — a celebration, a festival, if you will, all in one of the best cities in North America.

Ruth D. Williams, MD: Practicing ophthalmologists are a diverse group. So some people are people who like innovation and are very early on in adapting new innovations, and those people would naturally be here. But I would encourage any practitioner to come, just to get excited about what we do. Taking care of glaucoma day in and day up can be very discouraging, but coming to New Horizons and Glaucoma 360 creates that sense of hope and excitement about the future.

Alan S. Crandall, MD: There’s information that’s so practical to take home because you’ve got all of the stars of glaucoma here, and you’ll pick up… A practicing ophthalmologist will go home with at least one or two or three things, they’ll get better at treating glaucoma because of what they see here.

Richard L. Lindstrom, MD: Well, for the practicing ophthalmologist, it’s in San Francisco, which is one of our favorite cities. So it’s always fun to come to San Francisco. The hotel is special, and then you have an opportunity for a social event, which is the Gala banquet followed by all the new things that are happening in ophthalmology for a day, and then very helpful, direct clinician to clinician discussion on the following day. So, a very complete meeting in glaucoma.

Robert D. Fechtner, MD: I think the appeal of this meeting goes beyond just the academic and research ophthalmologists. Every ophthalmologist out there has patients with glaucoma, and having the broadest understanding of both the therapies now and the vision for the future is going to help us tailor our practices and incorporate those changes earlier. By coming to a meeting like this, you see what the progress is. And I can’t imagine you wouldn’t go home excited and wanting to do the latest and greatest.

End of transcript.